Effect of resveratrol on bone formation in the expanded inter-premaxillary suture: Early bone changes

Orthodontics and Craniofacial Research

Volumn 14, Issue 2, 2011, Pages 80-87

  Uysal, T ^a   Gorgulu, S ^b   Yagci, A ^c   Karslioglu, Y ^b   Gunhan, O ^b   Sagdic, D ^b  

^a IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

Author keywords

Image analysis; Maxillary expansion; Osteogenesis; Rats; Resveratrol

Indexed keywords

EID: 79953322623     PISSN: 16016335     EISSN: 16016343     Source Type: Journal    
DOI: 10.1111/j.1601-6343.2011.01511.x     Document Type: Article

References (34)

1. Saito S, Shimizu N. Stimulatory effects of low-power laser irradiation on bone regeneration in midpalatal suture during expansion in the rat. Am J Orthod Dentofacial Orthop 1997;111:525-32.
2. Sawada M, Shimizu N. Stimulation of bone formation in the expanding mid-palatal suture by transforming growth factor beta 1 in the rat. Eur J Orthod 1996;18:169-79.
3. Vardimon AD, Graber TM, Voss LR. Stability of magnetic versus mechanical palatal expansion. Eur J Orthod 1989;11:107-15.
4. Timms DJ. Long term follow-up of cases treated by rapid maxillary expansion. Trans Eur Orthod Soc 1976;52:211-5.
5. Haas AJ. The treatment of maxillary deficiency by opening the midpalatal suture. Angle Orthod 1965;35:200-17.
6. Cleall JF, Bayne DI, Posen JM, Subtelny JD. Expansion of the midpalatal suture in the monkey. Angle Orthod 1965;35:23-35.
7. Uysal T, Ustdal A, Sonmez MF, Ozturk F. Stimulation of bone formation by dietary boron in an orthopedically expanded suture in rabbits. Angle Orthod 2009;79:984-90.
8. Uysal T, Amasyali M, Enhos S, Sonmez MF, Sagdic D. Effect of ED-71, a new active vitamin D analog, on bone formation in an orthopedically expanded suture in rats. A histomorphometric study. Eur J Dent 2009;3:165-72.
9. Uysal T, Amasyali M, Olmez H, Karslioglu Y, Gunhan O. Stimulation of bone formation in the expanding inter-premaxillary suture by vitamin E, in rat. Korean J Orthod 2009;39:337-47.
10. Uysal T, Olmez H, Amasyali M, Karslioglu Y, Yoldas A, Gunhan O. Response of the expanded inter-premaxillary suture to intermittent compression. Early bone changes. Aust Orthod J 2010;26:49-55.
11. Uysal T, Amasyali M, Olmez H, Karslioglu Y, Gunhan O. Stimulation of bone formation by direct electrical current in an orthopedically expanded suture in the rat. Korean J Orthod 2010;40:106-14.
12. Uysal T, Amasyali M, Enhos S, Karslioglu Y, Yilmaz F, Gunhan O. Effect of periosteal stimulation therapy on bone formation in orthopedically expanded suture in rats. Orthod Craniofac Res 2010;13:89-95.
13. Chen RS, Wu PL, Chiou RY. Peanut roots as a source of resveratrol. J Agric Food Chem 2002;50:1665-7.
14. Elmali N, Baysal O, Harma A, Esenkaya I, Mizrak B. Effects of resveratrol in inflammatory arthritis. Inflammation 2007;30:1-6.
15. Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T, Delaissé JM. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res 2005;65:9943-52.
16. Song LH, Pan W, Yu YH, Quarles LD, Zhou HH, Xiao ZS. Resveratrol prevents CsA inhibition of proliferation and osteoblastic differentiation of mouse bone marrow-derived mesenchymal stem cells through an ER/NO/cGMP pathway. Toxicol In Vitro 2006;20:915-22.
17. Mizutani K, Ikeda K, Kawai Y, Yamori Y. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 1998;253:859-63.
18. Dai Z, Li Y, Quarles LD, Song T, Pan W, Zhou H et al. Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine 2007;14:806-14.
19. Rasband WS. Image-J. Bethesda, Maryland, USA: US National Institutes of Health; 19972008
20. Graber TM, Vanarsdall RL, Vig KWL. Orthodontics Current Principles and Techniques, 4th edn. Mosby: Elsevier; 2005. pp. 257-62.
21. Chang HN, Garetto LP, Potter RH, Katona TR, Lee CH, Roberts WE. Angiogenesis and osteogenesis in an orthopedically expanded suture. Am J Orthod Dentofacial Orthop 1997;111:382-90.
22. Turk C, Halici M, Guney A, Akgun H, Sahin V, Muhtaroglu S. Promotion of fracture healing by vitamin E in rats. J Int Med Res 2004;32:507-12.
23. Yilmaz C, Erdemli E, Selek H, Kinik H, Arikan M, Erdemli B. The contribution of vitamin C to healing of experimental fractures. Arch Orthop Trauma Surg 2001;121:426-8.
24. Sinha K, Chaudhary G, Gupta YK. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 2002;71:655-65.
25. Fremont L. Biological effects of resveratrol. Life Sci 2000;66:663-73.
26. Storey E. Tissue response to the movement of bones. Am J Orthod 1973;64:229-47.
27. Burstone CJ, Shafer WG. Sutural expansion by controlled mechanical stress in the rat. J Dent Res 1959;38:534-40.
28. Sarisözen B, Durak K, Dinçer G, Bilgen OF. The effects of vitamins E and C on fracture healing in rats. J Int Med Res 2002;30:309-13.
29. Juan ME, Vinardell MP, Planas JM. The daily oral administration of high doses of trans-resveratrol to rats for 28days is not harmful. J Nutr 2002;132:257-60.
30. Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS. Resveratrol-associated renal toxicity. Toxicol Sci 2004;82:614-9.
31. Su JL, Yang CY, Zhao M, Kuo ML, Yen ML. Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. J Biol Chem 2007;282:19385-98.
32. Liu ZP, Li WX, Yu B, Huang J, Sun J, Huo JS et al. Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model. J Med Food 2005;8:14-9.
33. Casper RF, Quesne M, Rogers IM, Shirota T, Jolivet A, Milgrom E et al. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol 1999;56:784-90.
34. Singh SU, Casper RF, Fritz PC, Sukhu B, Ganss B, Girard B Jr et al. Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol. J Endocrinol 2000;167:183-95.